OBJECTIVE: We have attempted to demonstrate the induction of inducible nitric oxide synthase in human vascular tissue and define the capacity of different cytokines to induce this enzyme. METHODS: Segments of human arteries were stimulated with lipopolysaccharide (10 micrograms/ml), interleukin-1 beta (5 U/ml), tumor necrosis factor-alpha (10 U/ml), and interferon-gamma (200 U/ml). Cytokines were either used alone or in certain combinations, as well as in the presence of L-NG-monomethyl-arginine (100 mumol/l) or cycloheximide (1 mumol/l). Induction was assessed by measurement of mRNA expression, immunocytochemical localisation of the expressed protein, nitric oxide synthase activity and levels of nitrite, a product of nitric oxide formation. RESULTS: PCR analysis showed the presence of mRNA for iNOS in stimulated samples which could be inhibited by cycloheximide. There was positive staining with an antibody against human iNOS in the media of stimulated vessel segments. Stimulated segments were also shown to contain Ca(2+)-independent nitric oxide synthase activity. The cytokines and lipopolysaccharide together gave a significant rise in levels of nitrite in the medium after 36 and 48 h, which was inhibited by L-NG-monomethyl-arginine and cycloheximide. Only interferon-gamma incubated alone was capable of increasing nitrite levels. This effect was enhanced by co-incubation with either interleukin-1 beta, tumor necrosis factor-alpha or lipopolysaccharide. CONCLUSION: We have shown that increased production of nitrite by human vascular tissue in response to cytokines is associated with induction of iNOS as shown at the molecular and protein levels, and further supported by the presence of increased Ca(2+)-independent nitric oxide synthase activity following cytokine stimulation.
OBJECTIVE: We have attempted to demonstrate the induction of inducible nitric oxide synthase in human vascular tissue and define the capacity of different cytokines to induce this enzyme. METHODS: Segments of human arteries were stimulated with lipopolysaccharide (10 micrograms/ml), interleukin-1 beta (5 U/ml), tumor necrosis factor-alpha (10 U/ml), and interferon-gamma (200 U/ml). Cytokines were either used alone or in certain combinations, as well as in the presence of L-NG-monomethyl-arginine (100 mumol/l) or cycloheximide (1 mumol/l). Induction was assessed by measurement of mRNA expression, immunocytochemical localisation of the expressed protein, nitric oxide synthase activity and levels of nitrite, a product of nitric oxide formation. RESULTS: PCR analysis showed the presence of mRNA for iNOS in stimulated samples which could be inhibited by cycloheximide. There was positive staining with an antibody against humaniNOS in the media of stimulated vessel segments. Stimulated segments were also shown to contain Ca(2+)-independent nitric oxide synthase activity. The cytokines and lipopolysaccharide together gave a significant rise in levels of nitrite in the medium after 36 and 48 h, which was inhibited by L-NG-monomethyl-arginine and cycloheximide. Only interferon-gamma incubated alone was capable of increasing nitrite levels. This effect was enhanced by co-incubation with either interleukin-1 beta, tumor necrosis factor-alpha or lipopolysaccharide. CONCLUSION: We have shown that increased production of nitrite by human vascular tissue in response to cytokines is associated with induction of iNOS as shown at the molecular and protein levels, and further supported by the presence of increased Ca(2+)-independent nitric oxide synthase activity following cytokine stimulation.
Authors: Valli Velayutham; Paul Z Benitez-Aguirre; Maria E Craig; Gerald Liew; Tien Y Wong; Alicia J Jenkins; Kim C Donaghue Journal: Diabetologia Date: 2017-07-15 Impact factor: 10.122
Authors: M Kamran Ikram; Xueling Sim; Sim Xueling; Richard A Jensen; Mary Frances Cotch; Alex W Hewitt; M Arfan Ikram; Jie Jin Wang; Ronald Klein; Barbara E K Klein; Monique M B Breteler; Ning Cheung; Gerald Liew; Paul Mitchell; Andre G Uitterlinden; Fernando Rivadeneira; Albert Hofman; Paulus T V M de Jong; Cornelia M van Duijn; Linda Kao; Ching-Yu Cheng; Albert Vernon Smith; Nicole L Glazer; Thomas Lumley; Barbara McKnight; Bruce M Psaty; Fridbert Jonasson; Gudny Eiriksdottir; Thor Aspelund; Tamara B Harris; Lenore J Launer; Kent D Taylor; Xiaohui Li; Sudha K Iyengar; Quansheng Xi; Theru A Sivakumaran; David A Mackey; Stuart Macgregor; Nicholas G Martin; Terri L Young; Josh C Bis; Kerri L Wiggins; Susan R Heckbert; Christopher J Hammond; Toby Andrew; Samantha Fahy; John Attia; Elizabeth G Holliday; Rodney J Scott; F M Amirul Islam; Jerome I Rotter; Annie K McAuley; Eric Boerwinkle; E Shyong Tai; Vilmundur Gudnason; David S Siscovick; Johannes R Vingerling; Tien Y Wong Journal: PLoS Genet Date: 2010-10-28 Impact factor: 5.917
Authors: Bo Lun Xu; Wen Li Zhou; Tie Pei Zhu; Ke Yun Cheng; Yi Jie Li; Hai Jing Zhan; Li Gang Jiang; Yu Hua Tong Journal: Sci Rep Date: 2019-07-29 Impact factor: 4.379
Authors: Klaus Burkhardt; Sonja Schwarz; Chengrui Pan; Felix Stelter; Konstantin Kotliar; Maxilian Von Eynatten; Daniel Sollinger; Ines Lanzl; Uwe Heemann; Marcus Baumann Journal: Cardiovasc Diabetol Date: 2009-02-20 Impact factor: 9.951
Authors: Bianca Harris; Ronald Klein; Michael Jerosch-Herold; Eric A Hoffman; Firas S Ahmed; David R Jacobs; Barbara E K Klein; Tien Y Wong; Joao A C Lima; Mary Frances Cotch; R Graham Barr Journal: PLoS One Date: 2012-12-20 Impact factor: 3.240